Riskpilot← Back to searchSign inGet full accessTeamNarkos Skövde AB
ABActiveOrg 5591747729Nedre Gustafsdalsvägen 9General medical practice activities · NACE 8621Est. 20180 employees
Revenue 2025
SEK 442K
+41% vs 2024
EBITDA margin
71.5%
+60% vs 2024
Equity ratio
72.2%
Financial strength
Net profit 2025
SEK 253K
+55% vs 2024
| Revenue | SEK 442K | +41% |
| EBITDA | SEK 316K | +60% |
| Net profit | SEK 253K | +55% |
| Total assets | SEK 420K | +45% |
| Equity | SEK 303K | +38% |
| Employees | 0 | — |
Legal name
TeamNarkos Skövde AB
Org number
5591747729
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 oktober 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva sjukvård, medicinsk konsultverksamhet inom öppen- och slutenvård samt bedriva utbildning inom sjukvård. Bolaget ska bedriva tjänster inom träning, hälsa och friskvård, såsom coachning, kurser, föreläsningar, träningsevenemang och träningsläger. Bolaget sak även förvalta värdepapper.
Address
Nedre Gustafsdalsvägen 9
Email
erikhjertonsson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 94 | 161 | 191 | 313 | 442 |
| Staff expenses | — | −92 | −49 | −40 | −54 |
| EBITDA | 28 | 27 | 97 | 198 | 316 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 28 | 27 | 97 | 198 | 316 |
| Net financials | — | 0 | 1 | 7 | 2 |
| Profit before tax | 28 | 27 | 98 | 205 | 318 |
| Tax | −6 | −5 | −20 | −42 | −65 |
| Net profit | 22 | 21 | 78 | 163 | 253 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 102 | 111 | 200 | 289 | 420 |
| Equity | 98 | 80 | 157 | 220 | 303 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 3 | 31 | 43 | 69 | 117 |
| Total debt | 3 | 31 | 43 | 69 | 117 |
EBITDA margin
71.5%
This company
15.8%
Market median
+353% vs market
20212025
Equity ratio
72.2%
This company
38.2%
Market median
+89% vs market
20212025
Return on equity
83.4%
This company
18.4%
Market median
+353% vs market
20212025
Net profit margin
57.2%
This company
8.1%
Market median
+606% vs market
20212025
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20212025
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TeamNarkos Skövde AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linn Ingrid Caroline Hjertonsson | Deputy Board Member | 0 companies |
| Hans Erik Ragnar Hjertonsson | Board of Directors | 0 companies |
| Hans Georg Hjertonsson | Deputy Board Member | 0 companies |